Results for "The Role of Distributors in the U.S. Specialty Pharmaceuticals Value Chain"
HDA Survey Results Indicate More Preparation Necessary for Connecting EPCIS-Enabled Systems Before DSCSA Deadline
Data released by the Healthcare Distribution Alliance (HDA) indicate more preparation is needed to ensure all healthcare supply chain partners are ready to meet the requirements of the Drug Supply Chain Security Act (DSCSA). HDA’s latest EPCIS Implementation Benchmarking Survey provides a final report on supply chain partners’ progress toward the November 27, 2023, deadline to connect data systems to exchange serialized transaction data for all pharmaceuticals.
Fostering Inclusion: A Spotlight on HDA’s Asian American and Pacific Islander Employee Network
In honor of Asian American, Native Hawaiian and Pacific Islander (AANHPI) Heritage Month, we recognize the volunteer leaders of HDA’s new industry-wide Asian American and Pacific Islander Employee Network (APEN) employee resource group (ERG). APEN ERG lead Vidhya Krishnamoorthy, Director of IT, Specialty Physician Services, for Cencora, and assistant lead Jason Chung, Director of Compliance for BluPax Pharma, discuss their aspirations for this group and reasons for participating.
HDA Shares Insights on Supply Chain Resilience and Drug Shortages at Duke-Margolis Conference
HDA President and CEO, Chip Davis, recently participated on a panel at the 2025 Duke Margolis Health Policy Conference.
